Vertex Pharmaceuticals: The Future Looks Bright, But It May Be A Choppy Ride

Vertex (NASDAQ: VRTX ) has a blossoming pipeline and continues to execute well. This article examines three commercial or nearly commercial products and the launch dynamics. While there may be volatility in share price, Vertex has a quality, maturing pipeline and a path Analyst's Disclosure: I/we have a beneficial long position in the shares of VRTX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation fo ...